BeOne Medicines CEO sells 60,218 ADS, exercises options
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
BeOne Medicines Ltd. CEO John Oyler exercised options for 60,218 American Depositary Shares at $36.90 and sold 60,218 ADS in open‑market trades in July 2026 at weighted‑average prices between $295.66 and $307.44 under a Rule 10b5‑1 plan, leaving no directly held ADS. The filing also lists 5,605,310 ordinary shares held directly as of July 10, 2026 and additional ordinary shares recorded as indirectly held through various trusts and a Roth IRA, with beneficial ownership disclaimed for several trust positions.
Insider Trade Summary 10b5-1
Exercise and sale activity reported; no spread calculated
Exercise and Sale
19 txns
Insider
OYLER JOHN
Role
Chief Executive Officer
Sold
60,218 shs ($18.26M)
Approx. gross sale proceeds
$18.26M
Approx. exercise cost
$2.22M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Share Option (Right to Buy) F22, F23 | 630,760 | $0.00 | $0.00 |
| Exercise | American Depositary Shares F6 | 48,520 | $36.90 | $1.79M |
| Sale | American Depositary Shares F6, F7, F15 | 798 | $301.9364 | $241K |
| Sale | American Depositary Shares F6, F7, F16 | 4,584 | $302.7881 | $1.39M |
| Sale | American Depositary Shares F6, F7, F17 | 26,294 | $303.8251 | $7.99M |
| Sale | American Depositary Shares F6, F7, F18 | 8,438 | $304.6803 | $2.57M |
| Sale | American Depositary Shares F6, F7, F19 | 846 | $305.5654 | $259K |
| Sale | American Depositary Shares F6, F7, F20 | 7,240 | $306.8245 | $2.22M |
| Sale | American Depositary Shares F6, F7, F21 | 320 | $307.405 | $98K |
| Exercise | Share Option (Right to Buy) F22, F23 | 152,074 | $0.00 | $0.00 |
| Exercise | American Depositary Shares F6 | 11,698 | $36.90 | $432K |
| Sale | American Depositary Shares F6, F7, F8 | 1,493 | $296.0672 | $442K |
| Sale | American Depositary Shares F6, F7, F9 | 1,314 | $297.2303 | $391K |
| Sale | American Depositary Shares F6, F7, F10 | 3,074 | $298.3516 | $917K |
| Sale | American Depositary Shares F6, F7, F11 | 5,143 | $298.9362 | $1.54M |
| Sale | American Depositary Shares F6, F7, F12 | 370 | $300.1199 | $111K |
| Sale | American Depositary Shares F6, F7, F13 | 150 | $301.1828 | $45K |
| Sale | American Depositary Shares F6, F7, F14 | 136 | $302.1911 | $41K |
| Sale | American Depositary Shares F6, F7 | 18 | $303.03 | $5K |
| Holding | Ordinary Shares | -- | -- | -- |
| Holding | Ordinary Shares F1 | -- | -- | -- |
| Holding | Ordinary Shares F2 | -- | -- | -- |
| Holding | Ordinary Shares F3 | -- | -- | -- |
| Holding | Ordinary Shares F4 | -- | -- | -- |
| Holding | Ordinary Shares F5 | -- | -- | -- |
Holdings After Transaction:
Share Option (Right to Buy) — 1,264,666 contracts (Direct);
American Depositary Shares — 0 shares (Direct);
Ordinary Shares — 5,605,310 shares (Direct);
Ordinary Shares — 46,031,994 shares (Indirect, See Footnote)
Footnotes (23)
- F1. These securities are held by the P&O Trust, the beneficiaries of which include the Reporting Person's child and others, for which the Reporting Person disclaims beneficial ownership.
- F2. These securities are held in a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership.
- F3. These securities are held by Oyler Investment LLC, of which 99% of the the limited liability company interests are owned by a grantor retain annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership.
- F4. These securities are held for the benefit of the Reporting Person in a Roth IRA PENSCO trust account.
- F5. These securities are held by The John Oyler Legacy Trust for the benefit of the Reporting Person's child, for which the Reporting Person disclaims beneficial ownership.
- F6. Each American Depositary Share represents 13 Ordinary Shares.
- F7. The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2026.
- F8. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $295.66 to $296.65, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- F9. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $296.66 to $297.64, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- F10. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $297.67 to $298.66, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- F11. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $298.68 to $299.59, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- F12. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $299.68 to $300.61, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- F13. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $300.69 to $301.47, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- F14. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $301.95 to $302.25, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- F15. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $301.23 to $302.19, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- F16. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $302.29 to $303.27, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- F17. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $303.30 to $304.29, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- F18. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $304.30 to $305.26, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- F19. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $305.30 to $306.23, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- F20. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $306.32 to $307.26, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- F21. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $307.35 to $307.44, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- F22. The number of securities underlying each option and the exercise price therefore are represented in ordinary shares.
- F23. These securities vest over a four-year period as follows: 25% on July 13, 2017, and the remaining in 36 successive equal monthly installments, subject to continued service. Unvested shares subject to this option are subject to accelerated vesting upon a change in control or certain termination events.
Key Figures
American Depositary Shares sold: 60218 American Depositary Shares
ADS option exercise price: $36.90 per American Depositary Share
Sale price range low: $295.66 per American Depositary Share
+4 more
7 metrics
American Depositary Shares sold
60218 American Depositary Shares
Total open-market sales reported on 2026-07-10 and 2026-07-13
ADS option exercise price
$36.90 per American Depositary Share
Exercise price for ADS options exercised in July 2026
Sale price range low
$295.66 per American Depositary Share
Lowest weighted-average sale price range disclosed in footnotes
Sale price range high
$307.44 per American Depositary Share
Highest weighted-average sale price range disclosed in footnotes
Underlying shares in derivative exercises
782834 Ordinary Shares
Total underlying ordinary shares for derivative option exercises at $2.84
Direct ordinary share holding
5605310 Ordinary Shares
Direct ownership recorded as of 2026-07-10
ADS to ordinary share ratio
1 American Depositary Share = 13 Ordinary Shares
Stated relationship between ADS and Ordinary Shares
Key Terms
American Depositary Shares, Rule 10b5-1 trading plan, grantor retained annuity trust, beneficial ownership, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
grantor retained annuity trust financial
"These securities are held in a grantor retained annuity trust, of which"
A grantor retained annuity trust (GRAT) is an estate-planning tool where the person who creates the trust transfers assets into it but receives fixed cash payments (an annuity) from the trust for a set number of years; whatever remains after that term passes to designated beneficiaries. It matters to investors because it can shift future appreciation of assets out of the creator’s taxable estate—like putting an asset into a timed vending machine that pays you fixed amounts while any extra value that grows inside the machine goes to heirs with reduced gift or estate tax consequences.
beneficial ownership regulatory
"for which the Reporting Person disclaims beneficial ownership."
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider stock activity did BeOne Medicines (ONC) report for its CEO?
BeOne Medicines CEO John Oyler reported an exercise-and-sale pattern involving American Depositary Shares. He exercised options for 60,218 ADS at $36.90 and sold 60,218 ADS in open-market trades in July 2026 at weighted-average prices between $295.66 and $307.44.
What option exercises by the BeOne Medicines (ONC) CEO are disclosed?
The filing shows Oyler exercising options into American Depositary Shares at $36.90 per ADS and separate derivative option exercises covering 782,834 underlying ordinary shares at $2.84 per share, with those options having an expiration date of November 15, 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.
